• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

2 dead after small plane crashes into Florida lake

admin - Latest News - November 11, 2025
admin
15 views 6 secs 0 Comments



2 dead after small plane crashes into Florida lake



Source link

TAGS:
PREVIOUS
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 11, 2025, 9:16 AM ESTBy Minyvonne BurkeThree original paintings by Bob Ross are set to be auctioned off Tuesday as part of a series to help raise money for public television stations after the Trump administration cut funding. The pieces were featured in the famed painter’s beloved show “The Joy of Painting,” which introduced the art form to millions of people. He hosted the show from 1983 until 1994, one year before he died. The three pieces set to be sold by the auction house Bonhams are: “Cliffside,” painted in 1990; “Winter’s Peace,” painted in 1993; and “Home in the Valley,” painted in 1993. Bids range from $25,000 to $50,000. Three paintings by Bob Ross to be auctioned by Bonhams. Bob Ross / Bonhams / APTRoss’ signature appears in the lower left corner of all three paintings.Joan Kowalski, president of Bob Ross Inc., said in an October statement announcing the auction that the sale ensures Ross’ “legacy continues to support the very medium that brought his joy and creativity into American homes for decades.”The auction is set to begin at 4 p.m. ET in Los Angeles. President Donald Trump signed an executive order in May to end public funding of PBS and National Public Radio to stop what he called “biased and partisan news coverage.” The White House had said that the organizations received “tens of millions of dollars” in taxpayers’ dollars to spread “radical, woke propaganda disguised as ‘news.'”Under Trump’s order, the Corporation for Public Broadcasting was directed to cut funding to the organizations to the extent allowed by law. Hundreds of PBS and NPR stations were forced to quickly find alternative funding, The Associated Press reported. Some stations had to lay off workers and cut programs, while others resorted to emergency fund drives. Bonhams said all net proceeds from the sale will go to American Public Television and to PBS public television stations nationwide. In total, 30 of Ross’ paintings are expected to be sold at different auctions. The auctions of the 30 paintings are estimated to total $850,000 to $1.4 million, Bonhams said. The other auctions will be announced at a later date. Minyvonne BurkeMinyvonne Burke is a senior breaking news reporter for NBC News.
NEXT
Explosives are used to reach South Korean workers
Related Post
November 8, 2025
Nov. 8, 2025, 6:00 AM ESTBy Evan BushNine seismic stations in Alaska are set to go dark this month, leaving tsunami forecasters without important data used to determine whether an earthquake will send a destructive wave barreling toward the West Coast. The stations relied on a federal grant that lapsed last year; this fall, the Trump administration declined to renew it. Data from the stations helps researchers determine the magnitude and shape of earthquakes along the Alaskan Subduction Zone, a fault that can produce some of the most powerful quakes in the world and put California, Oregon, Washington and Hawaii at risk. Losing the stations could lead Alaska’s coastal communities to receive delayed notice of an impending tsunami, according to Michael West, the director of the Alaska Earthquake Center. And communities farther away, like in Washington state, could get a less precise forecast.“In sheer statistics, the last domestic tsunami came from Alaska, and the next one likely will,” he said.It’s the latest blow to the U.S.’ tsunami warning system, which was already struggling with disinvestment and understaffing. Researchers said they are concerned that the network is beginning to crumble. “All the things in the tsunami warning system are going backwards,” West said. “There’s a compound problem.”The U.S. has two tsunami warning centers — one in Palmer, Alaska, and the other in Honolulu — that operate around-the-clock making predictions that help emergency managers determine whether coastal evacuations are necessary after an earthquake. The data from Alaska’s seismic stations has historically fed into the centers.Both centers are already short-staffed. Of the 20 full-time positions at the center in Alaska, only 11 are currently filled, according to Tom Fahy, the union legislative director for the National Weather Service Employees Organization. In Hawaii, four of the 16 roles are open. (Both locations are in the process of hiring scientists, Fahy said.)Additionally, the National Oceanographic and Atmospheric Administration has decreased funding for the National Tsunami Hazard Mitigation Program, which pays for the majority of states’ tsunami risk reduction work. The agency provided $4 million in 2025 — far less than the $6 million it has historically offered. “It’s on life support,” West said of the program. A tsunami evacuation route sign in Bolinas, Calif.Stephen Lam / San Francisco Chronicle via Getty Images fileOn top of that, NOAA laid off the National Weather Service’s tsunami program manager, Corina Allen, as part of the Trump administration’s firing of probationary workers in February, according to Harold Tobin, the Washington state seismologist. Allen, who had recently started at the agency, declined to comment via a spokesperson for her new employer, the Washington State Department of Natural Resources. These recent cuts have played out amid the Trump administration’s broader efforts to slash federal spending on science and climate research, among other areas. NOAA fired hundreds of workers in February, curtailed weather balloon launches and halted research on the costs of climate and weather disasters, among other cuts. Most of the seismic stations being shut down in Alaska are in remote areas of the Aleutian Islands, West said. The chain extends west from the Alaskan Peninsula toward Russia, tracing an underwater subduction zone. KHNS, a public radio station in Alaska, first reported the news that the stations would be taken offline.A NOAA grant for about $300,000 each year had supported the stations. The Alaska Earthquake Center requested new grant funding through 2028, but it was denied, according to an email between West and NOAA staffers that was viewed by NBC News. Kim Doster, a NOAA spokeswoman, said the federal agency stopped providing the money in 2024 under the Biden administration. In the spring, the University of Alaska Fairbanks ponied up funds to keep the program going for another year, believing that the federal government would ultimately cover the cost, said Uma Bhatt, a University of Alaska Fairbanks professor and associate director of the research institute that administered the grant. But new funds never materialized.“The loss of these observations does not prevent the Tsunami Warning Center from being able to carry out its mission,” Doster said. “The AEC [Alaska Earthquake Center] is one of many partners supporting the National Weather Service’s tsunami operations, and NWS continues to use many mechanisms to ensure the collection of seismic data across the state of Alaska.”The White House did not respond to a request for comment. West said the Alaska Earthquake Center provides the majority of data used for tsunami warnings in the state. The grant that supported the nine seismic stations also funded a data feed with information from the center’s other sensors, according to West. The national tsunami warning centers will no longer have direct access to the feed. West said the stations on the Aleutian Islands cover a huge geographic range. “There’s nothing else around,” he said. “It’s not like there’s another instrument 20 miles down the road. There’s no road.” The plan is to abandon the stations later this month and leave their equipment in place, West added. Tobin, in Washington state, said he worries that the closures “could delay or degrade the quality of tsunami warnings.” “This is a region that’s sparsely monitored. We kind of need to have a stethoscope on this region,” he said, adding: “These programs are in the background until a big, terrible event happens.”The Alaska-Aleutian subduction zone is one of the most active faults in the world and has produced significant tsunamis in the past. In 1964, a tsunami produced by a magnitude-9.2 earthquake killed 124 people, including 13 in California and five in Oregon, according to NOAA. Most of the California deaths were in Crescent City, where a 21-foot wave destroyed 29 city blocks, according to the city’s website.Tsunami experts said the stations in the Aleutian Islands are critical in quickly understanding nearby earthquakes. The closer a quake is to a sensor, the less uncertainty about a subsequent tsunami.NOAA’s tsunami warning centers aim to put out an initial forecast within five minutes, West said, which is critical for local communities. (A strong earthquake in the Aleutian Islands could send an initial wave into nearby Alaskan communities within minutes.) The only data available quickly enough to inform those initial forecasts comes from seismic signals (rather than tide gauges or pressure sensors attached to buoys).The warning centers then put out a more specific forecast of wave heights after about 40 minutes. Daniel Eungard, the tsunami program lead for the Washington Geological Survey, said that not having the Alaska sensors would create more uncertainty about the heights of waves expected, complicating decisions about whether to evacuate along the Washington coastline.“We try not to over-evacuate,” he said, adding that it costs time, money and trust if warnings prove unnecessary.How a massive quake off Russia sent tsunami waves across the Pacific02:55Over the last year, the national tsunami warning centers have had their hands full. A magnitude-7.0 earthquake near Cape Mendocino, California, triggered tsunami alerts along the state’s coast in December. In July, a magnitude-8.8 quake off Russia’s Kamchatka peninsula prompted a widespread alert along the U.S. West Coast. The peninsula is just west of the Aleutian Islands. NOAA helped build many of the seismic stations that have been part of the Alaska Earthquake Center’s network. But West said the agency has decreased its support over the past two decades; nine NOAA-built stations were decommissioned in 2013. “It’s now or never to decide whether or not NOAA is part of this,” he said. “What I really want to do is spark a discussion about tsunami efforts in the U.S. and have that not be triggered by the next devastating tsunami.”Evan BushEvan Bush is a science reporter for NBC News.
November 4, 2025
Marjorie Taylor Greene criticizes leaders on "The View"
September 27, 2025
Sept. 27, 2025, 5:30 AM EDTBy Berkeley Lovelace Jr.For people who rely on certain prescription drugs, including weight loss, asthma and cancer medications, President Donald Trump’s post announcing 100% tariffs on foreign brand-name drugs offers little clarity on when — or if — medications might see price hikes. “Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump said on Truth Social late Thursday. “‘IS BUILDING’ will be defined as, ‘breaking ground’ and/or ‘under construction.’ There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”Experts say Trump’s post raises a lot of questions. Here are five major ones. What drugs will be impacted?Trump’s post doesn’t specify whether brand-name drugmakers with an existing U.S. plant would be exempt, whether that exemption would include all their products, or whether it would only be for the drugs manufactured at the U.S. site. Novo Nordisk and Eli Lilly, makers of the weight loss drugs Wegovy and Zepound, respectively, have announced plans to invest in U.S. manufacturing. But it’s unclear if their intent to invest will warrant an exemption. On Tuesday, Lilly announced plans for a $6.5 billion manufacturing facility in Houston that will produce Zepbound and its other GLP-1 drug, Mounjaro, following a recent commitment to build a $5 billion plant near Richmond, Virginia. Novo Nordisk, a Danish company, said in June it would spend $4.1 billion to construct a second GLP-1 fill-finish plant in Clayton, North Carolina.AstraZeneca, which makes the asthma drug Symbicort, also announced in July that it will invest $50 billion over the next five years to expand its research and development and manufacturing footprint in the U.S. Many other popular brand-name drugs, however, are primarily manufactured overseas, particularly in Europe, said Rena Conti, an associate professor at Boston University’s Questrom School of Business.Botox, made by Allergen, and the cancer drug Keytruda from drugmaker Merck are made in Ireland. (Keytruda’s manufacturing has increasingly moved to the United States in recent years, but it’s not clear if that would earn an exemption from Trump’s tariffs.)Others, including some for blood and lung cancers, as well as vaccines, are made in places like India and China, Conti said. “I think what’s most at risk here are branded products that come from China and India,” she said. The E.U. and Japan already have trade agreements in place that cover pharmaceuticals, she added, and it’s unclear whether the new tariff will supersede that. Will patients see prices increase?Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are much cheaper and will not be affected by these tariffs. Whether patients see price increases will depend on how many drugmakers receive exemptions — and on whether companies choose to pass those costs on to patients at the pharmacy counter, said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School. ​​“Ultimately, tariffs are taxes on patients,” Kesselheim said, “and to the extent that drug companies see increases in cost due to tariffs, they will pass those costs on to patients.”Some companies may decide not to pass the costs along. So far, the 15% tariffs on imports from the E.U. haven’t translated into big price hikes for U.S. patients, Conti noted. To be sure, a 100% tariff would be far more costly for a company. Price hikes may not start right away, as drugmakers find out whether they qualify for an exemption. There also might be a lag since U.S. law prevents drugmakers from increasing the price of drugs faster than inflation.“What if you’re doing updates to the plant you currently have? What if you’re planning a facility? Do those count?” Kesselheim said. “It’s all very ambiguous.”Some patients may not notice additional price hikes at all, given how costly brand-name drugs already are in the U.S., said Arthur Caplan, the head of the Division of Medical Ethics at NYU Langone Medical Center in New York City. “I can certainly predict that some patients will immediately feel price increases that will shock them on some of these drugs,” Caplan said.Could insurers absorb the costs?Insurers and middlemen, known as pharmacy benefit managers, could try to negotiate drugmakers or absorb some of the tariff-related costs, Caplan said.It’s more likely, however, that they’d pass it on to patients in the short term, potentially in the form of a larger copay, he said.It’s not only patients with private insurance that should be worried about price hikes, Kesselheim said. Those who get their drugs covered through government health programs could also see price increases.“The government is the largest purchaser of prescription drugs in the market, through Medicare, Medicaid and the VA, so it’s really the government or government payers that are going to see the largest impact on price increases,” he said. Will tariffs spur more U.S. drug manufacturing?It’s unlikely, Kesselheim said. The decision to build a plant “is a complicated and expensive one” that requires several regulatory hurdles and years of planning.Conti noted that by the time new manufacturing plants are completed, Trump would likely be out of office.“It is somewhere between two years and five years to get new production facilities built,” she said, “and it can be in the millions of dollars depending on whether the product that you’re making is a small molecule drug or a biologic.”Even putting money back into an existing plant isn’t quick.“If you want to switch a line or retool a factory to make a product, then we’re talking about somewhere between 18 to 36 months to do that,” Conti said, “because you have to show the U.S. regulator that you can make it at this factory at scale, and the product is what it says it is, or is high quality and meets the quality standards of the U.S.”In a statement, Alex Schriver, a spokesperson for the trade group the Pharmaceutical Research and Manufacturers of America, said “most innovative medicines prescribed in America are already made in America” and companies continue to invest in the U.S.“Tariffs risk those plans because every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Schriver said. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”What about shortages?If Trump keeps his focus solely on brand-name drugs, U.S. patients are unlikely to face shortages, Kesselheim said.“Their profits are just so, so far beyond this tariff cost that they could probably be OK or raise the prices of the drugs,” he said. “They would probably not stop production as a result.”But that excludes, he added, some smaller companies who may make niche brand-name products and may not have the resources to take on the extra costs. If tariffs extend to generics, the risk is far greater, Caplan added. Unlike brand-name drugs, generic drugs are typically sold at close to the cost they’re made, he said, which makes it difficult for companies to justify the cost of building a new facility. They’d likely be forced to walk away from production or close their plants altogether.Berkeley Lovelace Jr.Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
October 5, 2025
Oct. 5, 2025, 5:01 AM EDTBy Freddie ClaytonPrime Minister Benjamin Netanyahu declared Israel and Hamas are on the brink of a hostage deal as President Donald Trump’s son-in-law and his Middle East envoy both traveled to the region for talks, raising hopes Sunday that the war in Gaza was on the verge of ending.Progress toward a ceasefire came after Hamas responded positively to Trump’s 20-point plan unveiled last week, pending conditions. Israeli attacks continued into Sunday, Gaza’s Civil Defense Spokesman Mahmoud Basal told NBC News, despite Trump’s calls to end the strikes. Of the 48 hostages remaining in Gaza, Israel believes 20 are still alive. Under the plan proposed by Trump, Hamas would have three days to release them.Trump has given the militant group until 6 p.m. E.T. Sunday to accept, and warned Hamas to move quickly, “or else all bets will be off.””When Hamas confirms, the Ceasefire will be IMMEDIATELY effective,” he said on Truth Social.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved